My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

12.38 -0.38 (-2.98%)

Streaming Delayed Price Updated: 3:43 PM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV

February 29, 2024

Via AB Newswire

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

February 26, 2024

Via ACCESSWIRE

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond ↗

February 25, 2024

When you want to light your afterburners, these ideas will do the trick.

Via InvestorPlace

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END

Via FinancialNewsMedia

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction

February 15, 2024

Via ACCESSWIRE

Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL

December 14, 2023

Via ACCESSWIRE

New Hope for Long COVID Sufferers

October 25, 2023

Via ACCESSWIRE

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

From FN Media Group LLC

Via GlobeNewswire

Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics

February 13, 2024

Via Get News

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial ↗

February 09, 2024

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...

Via Benzinga

New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval

February 01, 2024

Via ACCESSWIRE

New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval ↗

January 30, 2024

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting ↗

December 20, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 30.8% to $0.41 during Wednesday's session after the company announced it is securing up to $144 million in funding through...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 20, 2023

Via Benzinga

Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ: TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL ↗

December 14, 2023

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 17, 2023

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Stock Is Falling Sharply Today ↗

November 01, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 17% to $0.49 Wednesday morning. The company late Tuesday announced the topline results of a Phase 2 study for TNX-601 ER, a...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗

November 01, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 01, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!

Via InvestorPlace

New Hope For Long COVID Sufferers ↗

October 25, 2023

Tonix’s Therapeutic Development Program is Aligned with National Goal for Better Solutions TONIX: Effect of TNX-102 SL on Fatigue in Proof-of-Concept Phase 2 Study Sets Stage for Developing...

Via Benzinga

Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 29, 2023

Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 29, 2023

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Shares Are Getting Obliterated ↗

September 29, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 23.3% to $0.54 Friday morning after the company announced the pricing of a $4.5 million public offering of

Via Benzinga

This Meta Platforms Insider Just Sold $200,000 Worth of META Stock ↗

September 29, 2023

Meta Platforms stock is on the move Friday following an insider at the social media company selling $200,000 worth of shares.

Via InvestorPlace

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 29% Today? ↗

September 29, 2023

Tonix Pharmaceuticals stock is taking a beating on Friday after the company revealed details of an offering for TNXP shares.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 29, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition